106 related articles for article (PubMed ID: 9725204)
1. Autoimmunity without diabetes in transgenic mice expressing beta cell-specific CD86, but not CD80: parameters that trigger progression to diabetes.
Guerder S; Eynon EE; Flavell RA
J Immunol; 1998 Sep; 161(5):2128-40. PubMed ID: 9725204
[TBL] [Abstract][Full Text] [Related]
2. Role of costimulators in T cell differentiation: studies using antigen-presenting cells lacking expression of CD80 or CD86.
Schweitzer AN; Borriello F; Wong RC; Abbas AK; Sharpe AH
J Immunol; 1997 Mar; 158(6):2713-22. PubMed ID: 9058805
[TBL] [Abstract][Full Text] [Related]
3. Human fibroblasts transduced with CD80 or CD86 efficiently trans-costimulate CD4+ and CD8+ T lymphocytes in HLA-restricted reactions: implications for immune augmentation cancer therapy and autoimmunity.
Smythe JA; Fink PD; Logan GJ; Lees J; Rowe PB; Alexander IE
J Immunol; 1999 Sep; 163(6):3239-49. PubMed ID: 10477593
[TBL] [Abstract][Full Text] [Related]
4. High levels of Fas ligand and MHC class II in the absence of CD80 or CD86 expression and a decreased CD4+ T cell Infiltration, enables murine skin tumours to progress.
Byrne SN; Halliday GM
Cancer Immunol Immunother; 2003 Jun; 52(6):396-402. PubMed ID: 12739069
[TBL] [Abstract][Full Text] [Related]
5. Active CD4+ helper T cells directly stimulate CD8+ cytotoxic T lymphocyte responses in wild-type and MHC II gene knockout C57BL/6 mice and transgenic RIP-mOVA mice expressing islet beta-cell ovalbumin antigen leading to diabetes.
Ye Z; Ahmed KA; Hao S; Zhang X; Xie Y; Munegowda MA; Meng Q; Chibbar R; Xiang J
Autoimmunity; 2008 Nov; 41(7):501-11. PubMed ID: 18855194
[TBL] [Abstract][Full Text] [Related]
6. Induction of diabetes is influenced by the infectious virus and local expression of MHC class I and tumor necrosis factor-alpha.
Ohashi PS; Oehen S; Aichele P; Pircher H; Odermatt B; Herrera P; Higuchi Y; Buerki K; Hengartner H; Zinkernagel RM
J Immunol; 1993 Jun; 150(11):5185-94. PubMed ID: 8496610
[TBL] [Abstract][Full Text] [Related]
7. IFN-alpha induces autoimmune T cells through the induction of intracellular adhesion molecule-1 and B7.2.
Chakrabarti D; Hultgren B; Stewart TA
J Immunol; 1996 Jul; 157(2):522-8. PubMed ID: 8752897
[TBL] [Abstract][Full Text] [Related]
8. Expression of costimulatory molecules CD80 and/or CD86 by a Kaposi's sarcoma tumor cell line induces differential T-cell activation and proliferation.
Foreman KE; Wrone-Smith T; Krueger AE; Nickoloff BJ
Clin Immunol; 1999 Jun; 91(3):345-53. PubMed ID: 10370381
[TBL] [Abstract][Full Text] [Related]
9. CD86 (B7-2) can function to drive MHC-restricted antigen-specific CTL responses in vivo.
Agadjanyan MG; Kim JJ; Trivedi N; Wilson DM; Monzavi-Karbassi B; Morrison LD; Nottingham LK; Dentchev T; Tsai A; Dang K; Chalian AA; Maldonado MA; Williams WV; Weiner DB
J Immunol; 1999 Mar; 162(6):3417-27. PubMed ID: 10092797
[TBL] [Abstract][Full Text] [Related]
10. Studies using antigen-presenting cells lacking expression of both B7-1 (CD80) and B7-2 (CD86) show distinct requirements for B7 molecules during priming versus restimulation of Th2 but not Th1 cytokine production.
Schweitzer AN; Sharpe AH
J Immunol; 1998 Sep; 161(6):2762-71. PubMed ID: 9743334
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of CD28 engagement and IL-12 on T cell activation by altered peptide ligands.
Ding L; Shevach EM
J Immunol; 1998 Dec; 161(12):6614-21. PubMed ID: 9862689
[TBL] [Abstract][Full Text] [Related]
12. Distinct local immunogenic stimuli dictate differential requirements for CD4+ and CD8+ T cell subsets in the pathogenesis of spontaneous autoimmune diabetes.
Rajagopalan G; Mangalam AK; Sen MM; Kudva YC; David CS
Autoimmunity; 2007 Nov; 40(7):489-96. PubMed ID: 17966038
[TBL] [Abstract][Full Text] [Related]
13. B7.1 is a quantitatively stronger costimulus than B7.2 in the activation of naive CD8+ TCR-transgenic T cells.
Fields PE; Finch RJ; Gray GS; Zollner R; Thomas JL; Sturmhoefel K; Lee K; Wolf S; Gajewski TF; Fitch FW
J Immunol; 1998 Nov; 161(10):5268-75. PubMed ID: 9820499
[TBL] [Abstract][Full Text] [Related]
14. UVB-irradiated dendritic cells are impaired in their APC function and tolerize primed Th1 cells but not naive CD4+ T cells.
Denfeld RW; Hara H; Tesmann JP; Martin S; Simon JC
J Leukoc Biol; 2001 Apr; 69(4):548-54. PubMed ID: 11310840
[TBL] [Abstract][Full Text] [Related]
15. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
[TBL] [Abstract][Full Text] [Related]
16. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
Mukherjee S; Ahmed A; Nandi D
J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
[TBL] [Abstract][Full Text] [Related]
17. Changes in function of antigen-specific lymphocytes correlating with progression towards diabetes in a transgenic model.
Sarukhan A; Lanoue A; Franzke A; Brousse N; Buer J; von Boehmer H
EMBO J; 1998 Jan; 17(1):71-80. PubMed ID: 9427742
[TBL] [Abstract][Full Text] [Related]
18. The heterogeneous expression of CD80, CD86 and other adhesion molecules on leukemia and lymphoma cells and their induction by interferon.
Tsukada N; Aoki S; Maruyama S; Kishi K; Takahashi M; Aizawa Y
J Exp Clin Cancer Res; 1997 Jun; 16(2):171-6. PubMed ID: 9261743
[TBL] [Abstract][Full Text] [Related]
19. MHC class II and CD80 tumor cell-based vaccines are potent activators of type 1 CD4+ T lymphocytes provided they do not coexpress invariant chain.
Ilkovitch D; Ostrand-Rosenberg S
Cancer Immunol Immunother; 2004 Jun; 53(6):525-32. PubMed ID: 14730400
[TBL] [Abstract][Full Text] [Related]
20. Chronic ethanol ingestion by mice increases expression of CD80 and CD86 by activated macrophages.
Zhu X; Coleman RA; Alber C; Ballas ZK; Waldschmidt TJ; Ray NB; Krieg AM; Cook RT
Alcohol; 2004 Feb; 32(2):91-100. PubMed ID: 15163560
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
